SCHEMBL10464324

SCHEMBL10464324

OCc1csc(Nc2cccc(C(F)(F)F)c2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCP P55072 1/20 0.58
MAPT P10636 11/20 0.53
NPSR1 Q6W5P4 3/20 0.53
KDM4E B2RXH2 2/20 0.53
MAPK1 P28482 2/20 0.52
HPGD P15428 1/20 0.52
HTT P42858 1/20 0.52
GPR35 Q9HC97 1/20 0.52
CYP1A2 P05177 3/20 0.51
CYP3A4 P08684 3/20 0.51
CYP2D6 P10635 3/20 0.51
CYP2C9 P11712 3/20 0.51
CYP2C19 P33261 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 3/20 0.51
GAA P10253 3/20 0.50
IDH2 P48735 3/20 0.50
LMNA P02545 2/20 0.50
UBE2N P61088 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876936 0.87 VCP (0.61) VCPMAPTNPSR1KDM4EMAPK1
SCHEMBL14069823 0.84 MAPT (0.59) VCPMAPTNPSR1KDM4EMAPK1
SCHEMBL28007623 0.83 VCP (0.54) VCPMAPTNPSR1KDM4EMAPK1
SCHEMBL29274280 0.81 VCP (0.63) VCPMAPTNPSR1KDM4EMAPK1
SCHEMBL30956254 0.81 VCP (0.63) VCPMAPTNPSR1KDM4EMAPK1
SCHEMBL23539792 0.80 VCP (0.65) VCPMAPTNPSR1KDM4EMAPK1
SCHEMBL23540119 0.80 VCP (0.62) VCPMAPTNPSR1KDM4EMAPK1
SCHEMBL30041339 0.80 VCP (0.62) VCPMAPTNPSR1KDM4EMAPK1
SCHEMBL18342170 0.80 MEN1 (0.53) MAPTMAPK1HTTMEN1KMT2A
SCHEMBL10464778 0.78 GAA (0.57) VCPMAPTNPSR1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4933355-A ALDOSE REDUCTASE INHIBITORS SANKYO COMPANY LIMITED (JP) 1990-06-12 US disclosed
EP-0337819-A1 Thiazole derivatives, their preparation and their use in the treatment of diabetes complications Sankyo Company Limited (JP) 1989-10-18 EP disclosed